Newsletter | July 10, 2026

07.10.26 -- Cut Trial Delays & Optimize ADCs With Data-Driven Insights

FEATURED ARTICLE

Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho

On this week's episode of the Business of Biotech, William Ho, CEO of IN8bio, explains why gamma delta T cells may have an edge against cancer, including solid tumors like glioblastoma.

INDUSTRY INSIGHTS

Advancing ADCs With Expertise In Payloads And Linkers

See how integrated containment, high‑potency expertise, advanced chromatography, and linker–payload optimization speed your ADC from early development to commercial supply.

Wrangling Data With AI To Help Shape The Industry's Future

Uncover how biotech firms can harness emerging technologies and other AI-driven innovations to shape the future of data-powered healthcare and scientific discovery.

Reduction Of Screen Failures In A Biomarker

Targeted prescreening for biomarker and cognitive criteria cut screen failures in a complex Alzheimer’s trial, speeding enrollment and improving site efficiency while maintaining strict eligibility.

Strategic Early Material Generation For Accelerated Process Development

Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

Curia Capabilities Update May 2026: HPAPI & API Development

What is critical when choosing a CDMO as a partner for HPAPI development and manufacturing? Curia's Brian Haney breaks down the key questions, controls, and expertise every innovator should evaluate.

Connect With Life Science Leader: